Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Clinical trial NCT07166094 · RECRUITING
Trial details
- NCT number
- NCT07166094
- Sponsor
- Genmab
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-28
- Primary completion
- 2029-08-01
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.